Volume No. :   9

Issue No. :  1

Year :  2019

ISSN Print :  2231-5667

ISSN Online :  2231-5675


Registration

Allready Registrered
Click to Login

Swine Flu and its Recent Medicines



Address:   Manohar D. Kengar*, Amit A. Jadhav, Rahul P. Jadhav, Prathmesh L. Jarag, Sanmati D. Shete
Rajarambapu College of Pharmacy, Kasegaon, Dist – Sangli, Maharashtra, India – 415404
*Corresponding Author
DOI No: 10.5958/2231-5675.2019.00008.5

ABSTRACT:
The H1NI flu infection is novel influenza virus do not differ from those of seasonal human influenza, there is a continued need for sub typing and laboratory confirmation according to WHO estimates, 1/3rd of the world’s population will be affected with H1N1flu within two years in India. The most common cause of H1N1viruse to death from the virus is respiratory failure, but other causes of mortality include sepsis, dehydration and electrolyte imbalance. WHO revised the phase descriptions in 2009 and has retained the use of six phases in regards to pandemics to allow for the incorporation of new recommendations and approaches into existing national preparedness and response plans. Prevention of transmission from pig to human Swine can be infected by both avian and human influenza strains of influenza, and therefore are hosts where the antigenic shifts can occur that create new influenza strains and verious medicin available in market to triet the H1N1 flu.
KEYWORDS:
Swine flu, H1N1, influinza, helth care provider, medicin.
Cite:
Manohar D. Kengar, Amit A. Jadhav, Rahul P. Jadhav, Prathmesh L. Jarag, Sanmati D. Shete. Swine Flu and its Recent Medicines. Asian J. Pharm. Ana. 2019; 9(1):30-36.
[View HTML]     



Visitor's No. :   164107